Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Marzal-Alfaro, Belén
36  Ergebnisse:
Personensuche X
?
1

Complementary and alternative medicine in cancer patients: ..:

Escudero-Vilaplana, Vicente ; Collado-Borrell, Roberto ; Gómez Martínez-Sagrera, Patricia...
Journal of Cancer Research and Clinical Oncology.  149 (2022)  7 - p. 2855-2882 , 2022
Link: https://doi.org/10.1007/..
 
?
2

Smartphone-Based Ecological Momentary Assessment for the Me..:

Escudero-Vilaplana, Vicente ; Romero-Medrano, Lorena ; Villanueva-Bueno, Cristina...
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
3

DPYD Exome, mRNA Expression and Uracil Levels in Early Seve..:

Villalvazo, Priscila ; Marzal-Alfaro, Belén ; García-Alfonso, Pilar...
Journal of Personalized Medicine.  11 (2021)  8 - p. 792 , 2021
Link: https://doi.org/10.3390/..
 
?
4

Assessment of diarrhea as side effect of oral targeted anti..:

Escudero-Vilaplana, Vicente ; Collado-Borrell, Roberto ; del Monte-Millán, Maria...
Supportive Care in Cancer.  29 (2021)  8 - p. 4673-4681 , 2021
Link: https://doi.org/10.1007/..
 
?
5

Aggressiveness of end-of-life cancer care: what happens in ..:

García-Martín, Estela ; Escudero-Vilaplana, Vicente ; Fox, Bárbara...
Supportive Care in Cancer.  29 (2020)  6 - p. 3121-3127 , 2020
Link: https://doi.org/10.1007/..
 
?
6

A smartphone app to improve the safety of patients undergoi..:

Villanueva-Bueno, Cristina ; Collado-Borrell, Roberto ; Escudero-Vilaplana, Vicente...
Frontiers in Public Health.  10 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
7

A New Methodology to Estimate Drug Cost Avoidance in Clinic..:

García-Sánchez, Sebastián ; Collado-Borrell, Roberto ; González-Haba, Eva...
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
8

Chimeric Antigen Receptor T Cell Therapy Management and Saf..:

Marzal-Alfaro, María Belen ; Escudero-Vilaplana, Vicente ; Revuelta-Herrero, Jose Luis...
Frontiers in Oncology.  11 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
9

Smartphone-based ecological momentary assessment for the me..:

Escudero-Vilaplana, Vicente ; Romero-Medrano, Lorena ; Villanueva-Bueno, Cristina...
Comunidad de Madrid. IND2017/TIC-7618.  , 2022
Link: http://hdl.handle.net/10..
 
?
10

Smartphone-Based Ecological Momentary Assessment for the Me..:

Escudero-Vilaplana, Vicente ; Romero-Medrano, Lorena ; Villanueva-Bueno, Cristina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351705/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
11

DPYD Exome, mRNA Expression and Uracil Levels in Early Seve..:

Villalvazo, Priscila ; Marzal-Alfaro, Belén ; García-Alfonso, Pilar...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401253/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
12

Development and Evaluation of a Clinical Decision Support S..:

Ibáñez-Garcia, Sara ; Rodriguez-Gonzalez, Carmen ; Escudero-Vilaplana, Vicente...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637024/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
13

Standardizing Health Outcomes for Lung Cancer. Adaptation o..:

Escudero-Vilaplana, Vicente ; Calles, Antonio ; Collado-Borrell, Roberto...
Frontiers in Oncology.  10 (2020)  - p. , 2020
Link: https://doi.org/10.3389/..
 
?
14

A New Methodology to Estimate Drug Cost Avoidance in Clinic..:

García-Sánchez, Sebastián ; Collado-Borrell, Roberto ; González-Haba, Eva...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213877/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
15

Chimeric Antigen Receptor T Cell Therapy Management and Saf..:

Marzal-Alfaro, María Belen ; Escudero-Vilaplana, Vicente ; Revuelta-Herrero, Jose Luis...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992774/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
1-15